These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 16517226)
1. Mass spectrometry for congenital disorders of glycosylation, CDG. Wada Y J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in the characterization of human genetic N-glycosylation defects. Barone R; Sturiale L; Garozzo D Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296 [TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry in the detection and diagnosis of congenital disorders of glycosylation. Wada Y Eur J Mass Spectrom (Chichester); 2007; 13(1):101-3. PubMed ID: 17878547 [TBL] [Abstract][Full Text] [Related]
4. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis. Faid V; Chirat F; Seta N; Foulquier F; Morelle W Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology. Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784 [TBL] [Abstract][Full Text] [Related]
6. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS. Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764 [TBL] [Abstract][Full Text] [Related]
7. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475 [TBL] [Abstract][Full Text] [Related]
8. [Congenital disorders of glycosylation]. Durand G; Dupré T; Vuillaumier-Barrot S; Seta N Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291 [TBL] [Abstract][Full Text] [Related]
9. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599 [TBL] [Abstract][Full Text] [Related]
10. Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis. Kleinert P; Kuster T; Arnold D; Jaeken J; Heizmann CW; Troxler H Proteomics; 2007 Jan; 7(1):15-22. PubMed ID: 17152094 [TBL] [Abstract][Full Text] [Related]
11. Methods in enzymology: O-glycosylation of proteins. Peter-Katalinić J Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314 [TBL] [Abstract][Full Text] [Related]
12. Screening and diagnosis of congenital disorders of glycosylation. Marklová E; Albahri Z Clin Chim Acta; 2007 Oct; 385(1-2):6-20. PubMed ID: 17716641 [TBL] [Abstract][Full Text] [Related]
13. The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random. Mills K; Mills PB; Clayton PT; Mian N; Johnson AW; Winchester BG Glycobiology; 2003 Feb; 13(2):73-85. PubMed ID: 12626422 [TBL] [Abstract][Full Text] [Related]
14. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups. Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491 [TBL] [Abstract][Full Text] [Related]
15. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172 [TBL] [Abstract][Full Text] [Related]
16. Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects. Leroy JG Pediatr Res; 2006 Dec; 60(6):643-56. PubMed ID: 17065563 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488 [TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms. Babovic-Vuksanovic D; O'Brien JF Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx. Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642 [TBL] [Abstract][Full Text] [Related]
20. Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm. Ethier M; Krokhin O; Ens W; Standing KG; Wilkins JA; Perreault H Rapid Commun Mass Spectrom; 2005; 19(5):721-7. PubMed ID: 15702487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]